290 related articles for article (PubMed ID: 9115216)
1. Monocyte chemotactic protein-2 (MCP-2) uses CCR1 and CCR2B as its functional receptors.
Gong X; Gong W; Kuhns DB; Ben-Baruch A; Howard OM; Wang JM
J Biol Chem; 1997 May; 272(18):11682-5. PubMed ID: 9115216
[TBL] [Abstract][Full Text] [Related]
2. Cloning and functional characterization of the rabbit C-C chemokine receptor 2.
Lu D; Yuan XJ; Evans RJ; Pappas AT; Wang H; Su EW; Hamdouchi C; Venkataraman C
BMC Immunol; 2005 Jul; 6():15. PubMed ID: 16001983
[TBL] [Abstract][Full Text] [Related]
3. The second extracellular loop of CCR5 is the major determinant of ligand specificity.
Samson M; LaRosa G; Libert F; Paindavoine P; Detheux M; Vassart G; Parmentier M
J Biol Chem; 1997 Oct; 272(40):24934-41. PubMed ID: 9312096
[TBL] [Abstract][Full Text] [Related]
4. Characterization of binding sites for chemokines MCP-1 and MIP-1alpha on human brain microvessels.
Andjelkovic AV; Pachter JS
J Neurochem; 2000 Nov; 75(5):1898-906. PubMed ID: 11032879
[TBL] [Abstract][Full Text] [Related]
5. Monocyte chemoattractant protein-3 is a functional ligand for CC chemokine receptors 1 and 2B.
Combadiere C; Ahuja SK; Van Damme J; Tiffany HL; Gao JL; Murphy PM
J Biol Chem; 1995 Dec; 270(50):29671-5. PubMed ID: 8530354
[TBL] [Abstract][Full Text] [Related]
6. CCR1 chemokines promote the chemotactic recruitment, RANKL development, and motility of osteoclasts and are induced by inflammatory cytokines in osteoblasts.
Yu X; Huang Y; Collin-Osdoby P; Osdoby P
J Bone Miner Res; 2004 Dec; 19(12):2065-77. PubMed ID: 15537451
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of the chemokine receptor, hCCR1 in a stable transfectant and differentiated HL-60 cells: antagonism of hCCR1 activation by MIP-1beta.
Chou CC; Fine JS; Pugliese-Sivo C; Gonsiorek W; Davies L; Deno G; Petro M; Schwarz M; Zavodny PJ; Hipkin RW
Br J Pharmacol; 2002 Nov; 137(5):663-75. PubMed ID: 12381680
[TBL] [Abstract][Full Text] [Related]
8. Chemokine receptor expression and chemotactic responsiveness of human monocytes after influenza A virus infection.
Salentin R; Gemsa D; Sprenger H; Kaufmann A
J Leukoc Biol; 2003 Aug; 74(2):252-9. PubMed ID: 12885942
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the signal transduction pathway activated in human monocytes and dendritic cells by MPIF-1, a specific ligand for CC chemokine receptor 1.
Nardelli B; Tiffany HL; Bong GW; Yourey PA; Morahan DK; Li Y; Murphy PM; Alderson RF
J Immunol; 1999 Jan; 162(1):435-44. PubMed ID: 9886417
[TBL] [Abstract][Full Text] [Related]
10. Monocyte chemoattractant protein-2 is a potent agonist of CCR2B.
Moore UM; Kaplow JM; Pleass RD; Castro SW; Naik K; Lynch CN; Daly S; Roach AG; Jaye M; Williams RJ
J Leukoc Biol; 1997 Dec; 62(6):911-5. PubMed ID: 9400834
[TBL] [Abstract][Full Text] [Related]
11. Differential chemokine activation of CC chemokine receptor 1-regulated pathways: ligand selective activation of Galpha 14-coupled pathways.
Tian Y; New DC; Yung LY; Allen RA; Slocombe PM; Twomey BM; Lee MMK; Wong YH
Eur J Immunol; 2004 Mar; 34(3):785-795. PubMed ID: 14991608
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways.
Sabroe I; Hartnell A; Jopling LA; Bel S; Ponath PD; Pease JE; Collins PD; Williams TJ
J Immunol; 1999 Mar; 162(5):2946-55. PubMed ID: 10072545
[TBL] [Abstract][Full Text] [Related]
13. Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta, and MIP-1alpha.
Raport CJ; Gosling J; Schweickart VL; Gray PW; Charo IF
J Biol Chem; 1996 Jul; 271(29):17161-6. PubMed ID: 8663314
[TBL] [Abstract][Full Text] [Related]
14. MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4.
Ramos CD; Canetti C; Souto JT; Silva JS; Hogaboam CM; Ferreira SH; Cunha FQ
J Leukoc Biol; 2005 Jul; 78(1):167-77. PubMed ID: 15831559
[TBL] [Abstract][Full Text] [Related]
15. The T cell-directed CC chemokine TARC is a highly specific biological ligand for CC chemokine receptor 4.
Imai T; Baba M; Nishimura M; Kakizaki M; Takagi S; Yoshie O
J Biol Chem; 1997 Jun; 272(23):15036-42. PubMed ID: 9169480
[TBL] [Abstract][Full Text] [Related]
16. Binding of RANTES, MCP-1, MCP-3, and MIP-1alpha to cells in human skin.
Hub E; Rot A
Am J Pathol; 1998 Mar; 152(3):749-57. PubMed ID: 9502417
[TBL] [Abstract][Full Text] [Related]
17. Production of the novel C-C chemokine MCP-4 by airway cells and comparison of its biological activity to other C-C chemokines.
Stellato C; Collins P; Ponath PD; Soler D; Newman W; La Rosa G; Li H; White J; Schwiebert LM; Bickel C; Liu M; Bochner BS; Williams T; Schleimer RP
J Clin Invest; 1997 Mar; 99(5):926-36. PubMed ID: 9062350
[TBL] [Abstract][Full Text] [Related]
18. CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist.
Blanpain C; Migeotte I; Lee B; Vakili J; Doranz BJ; Govaerts C; Vassart G; Doms RW; Parmentier M
Blood; 1999 Sep; 94(6):1899-905. PubMed ID: 10477718
[TBL] [Abstract][Full Text] [Related]
19. CCR5 has an expanded ligand-binding repertoire and is the primary receptor used by MCP-2 on activated T cells.
Ruffing N; Sullivan N; Sharmeen L; Sodroski J; Wu L
Cell Immunol; 1998 Nov; 189(2):160-8. PubMed ID: 9790730
[TBL] [Abstract][Full Text] [Related]
20. Identification of C-C chemokine receptor 1 (CCR1) as the monocyte hemofiltrate C-C chemokine (HCC)-1 receptor.
Tsou CL; Gladue RP; Carroll LA; Paradis T; Boyd JG; Nelson RT; Neote K; Charo IF
J Exp Med; 1998 Aug; 188(3):603-8. PubMed ID: 9687537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
